Author Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging

Neurology. 2024 May 14;102(9):e209377. doi: 10.1212/WNL.0000000000209377. Epub 2024 Apr 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Alzheimer Disease / drug therapy
  • Amyloid beta-Peptides
  • Cognitive Aging*
  • Humans

Substances

  • Amyloid beta-Peptides